These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19217153)

  • 1. Ustekinumab for psoriatic arthritis.
    Cuchacovich RS; Espinoza LR
    Lancet; 2009 Feb; 373(9664):605-6. PubMed ID: 19217153
    [No Abstract]   [Full Text] [Related]  

  • 2. Ustekinumab for psoriasis and psoriatic arthritis.
    Goldminz AM; Gottlieb AB
    J Rheumatol Suppl; 2012 Jul; 89():86-9. PubMed ID: 22751602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial.
    Gottlieb A; Menter A; Mendelsohn A; Shen YK; Li S; Guzzo C; Fretzin S; Kunynetz R; Kavanaugh A
    Lancet; 2009 Feb; 373(9664):633-40. PubMed ID: 19217154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adalimumab therapy of psoriasis and psoriatic arthritis in a patient with cirrhosis of the liver.
    Piel S; Dissemond J
    J Am Acad Dermatol; 2008 Nov; 59(5 Suppl):S117-8. PubMed ID: 19119119
    [No Abstract]   [Full Text] [Related]  

  • 5. Comment on: 'Paradoxical psoriatic arthritis in a patient with psoriasis treated with guselkumab'.
    Akturk S; Altunisik N; Buyukavci R; Turkmen D
    Clin Exp Dermatol; 2022 Jul; 47(7):1363-1364. PubMed ID: 35266569
    [No Abstract]   [Full Text] [Related]  

  • 6. Spotlight on ustekinumab in moderate to severe plaque psoriasis.
    Croxtall JD
    Am J Clin Dermatol; 2012 Apr; 13(2):135-7. PubMed ID: 22201419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ustekinumab for resistant psoriatic arthritis.
    Wallis DE; Waldron NM; Korendowych E
    J Rheumatol; 2013 Feb; 40(2):207. PubMed ID: 23378500
    [No Abstract]   [Full Text] [Related]  

  • 8. A case of severe psoriatic arthritis with hands flexion contracture and palmar psoriasis successfully treated with guselkumab.
    Megna M; Marano L; Camela E; Potestio L; Fabbrocini G; Scalvenzi M; Guerrasio G
    Dermatol Ther; 2022 Oct; 35(10):e15766. PubMed ID: 35959513
    [No Abstract]   [Full Text] [Related]  

  • 9. Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics.
    Papoutsaki M; Chimenti MS; Costanzo A; Talamonti M; Zangrilli A; Giunta A; Bianchi L; Chimenti S
    J Am Acad Dermatol; 2007 Aug; 57(2):269-75. PubMed ID: 17574299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of adalimumab on symptoms of psoriatic arthritis in patients with moderate to severe psoriasis: a pooled analysis of randomized clinical trials.
    Mease PJ; Signorovitch J; Yu AP; Wu EQ; Gupta SR; Bao Y; Mulani PM
    Dermatology; 2010; 220(1):1-7. PubMed ID: 19940437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of severe psoriasis and psoriatic arthritis with adalimumab.
    Chew AL; Bennett A; Smith CH; Barker J; Kirkham B
    Br J Dermatol; 2004 Aug; 151(2):492-6. PubMed ID: 15327561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).
    Antoni CE; Kavanaugh A; Kirkham B; Tutuncu Z; Burmester GR; Schneider U; Furst DE; Molitor J; Keystone E; Gladman D; Manger B; Wassenberg S; Weier R; Wallace DJ; Weisman MH; Kalden JR; Smolen J
    Arthritis Rheum; 2005 Apr; 52(4):1227-36. PubMed ID: 15818699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infliximab monotherapy in Japanese patients with moderate-to-severe plaque psoriasis and psoriatic arthritis. A randomized, double-blind, placebo-controlled multicenter trial.
    Torii H; Nakagawa H;
    J Dermatol Sci; 2010 Jul; 59(1):40-9. PubMed ID: 20547039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of psoriasis/psoriatic arthritis with inflammatory bowel disease influences management strategy.
    Shaw CA; Kole LCS; Elewski BE
    J Eur Acad Dermatol Venereol; 2019 Nov; 33(11):e431-e432. PubMed ID: 31220373
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial.
    McInnes IB; Kavanaugh A; Gottlieb AB; Puig L; Rahman P; Ritchlin C; Brodmerkel C; Li S; Wang Y; Mendelsohn AM; Doyle MK;
    Lancet; 2013 Aug; 382(9894):780-9. PubMed ID: 23769296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ustekinumab for the treatment of psoriatic arthritis.
    Chandler DJ; Bewley A
    Expert Rev Clin Pharmacol; 2014 Mar; 7(2):111-21. PubMed ID: 24494794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psoriatic arthritis in 2015: Advancement continues in imaging, tight control and new drugs.
    Olivieri I; D'Angelo S
    Nat Rev Rheumatol; 2016 Feb; 12(2):76-8. PubMed ID: 26794864
    [No Abstract]   [Full Text] [Related]  

  • 18. New biologics for psoriasis and psoriatic arthritis.
    Rozenblit M; Lebwohl M
    Dermatol Ther; 2009; 22(1):56-60. PubMed ID: 19222517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ustekinumab in the treatment of severe rupioid psoriasis: A case report.
    Necas M; Vasků V
    Acta Dermatovenerol Alp Pannonica Adriat; 2010; 19(2):23-7. PubMed ID: 20664917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Infliximab].
    Herrera E; Habicheyn S
    Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():7-13. PubMed ID: 19080986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.